Organto Provides Preliminary 2023 First Quarter Sales and Gross Profit Estimates - Seite 2
Organto also reported that the commercial and financial integration of the New Fruit Group, acquired in January 2023, is continuing and the Company expects to achieve targeted run rate revenues in the second half of 2023. The acquisition has significantly expanded the Company's product portfolio, customer base, and distribution channels, further enhancing its position as a leading provider of both organic and non-GMO value-added fruits and vegetables.
"The integration of the New Fruit Group acquisition has been a key focus for us, and we are pleased with our progress so far. We remain confident that this acquisition will help us achieve our long-term growth objectives and enhance our business profile." commented Rients van der Wal, Co-CEO of Organto Foods Inc. and CEO of Organto Europe BV. "We are also keenly focused on continuing to expand our branded products capabilities and distribution, further building out our digital platform technologies, onboarding new customers and suppliers, and leveraging our platform and supply chains to improve our operating results."
Investor Update
The Company also announced that it will host an Investor Update on Thursday, May 11th at 1:00 PM EST. The event will provide an opportunity for investors and stakeholders to hear directly from Organto's management team about the Company's recent developments, financial results, and growth strategy. Dial- in details below.
Topic: Organto Virtual Town Hall
Time: May 11, 2023 01:00 PM Eastern Time (US and Canada)
Join Zoom Meeting
https://us02web.zoom.us/j/84657580115?pwd=SDhIUTJQS2dBMkZVcFhDbzN2YlJz ...
Meeting ID: 846 5758 0115
Passcode: 341201
One tap mobile
+1 305 224 1968, , 84657580115# US
+1 309 205 3325, , 84657580115# US
Lesen Sie auch
Dial by your location
+1 305 224 1968 US
+1 309 205 3325 US
+1 312 626 6799 US (Chicago)
+1 346 248 7799 US (Houston)
+1 360 209 5623 US
+1 386 347 5053 US
+1 507 473 4847 US
+1 564 217 2000 US
+1 646 876 9923 US (New York)
+1 646 931 3860 US
+1 669 444 9171 US
+1 669 900 6833 US (San Jose)
+1 689 278 1000 US
+1 719 359 4580 US
+1 253 205 0468 US
+1 253 215 8782 US (Tacoma)
+1 301 715 8592 US (Washington DC)
Meeting ID: 846 5758 0115
Find your local number: https://us02web.zoom.us/u/kcn9PSy7C0
ON BEHALF OF ORGANTO,
Steve Bromley
Chair and Co-Chief Executive Officer
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.